{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:27:32Z","timestamp":1794072452547,"version":"4.8.0"},"reference-count":41,"publisher":"SAGE Publications","issue":"14","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize the burden of herpes zoster (HZ) in systemic lupus erythematosus (SLE) and to examine clinical correlates of HZ and patients\u2019 attitudes toward the recombinant zoster vaccine (RZV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a single-center retrospective cohort study combined with a cross-sectional survey among consecutive adult outpatients with SLE between December 2024 and June 2025. HZ episodes after SLE diagnosis were ascertained via structured interviews. Incidence rates were calculated as the number of HZ episodes per 1000 person-years from SLE diagnosis to enrollment. Participants were classified into three groups according to the number of HZ episodes: HZ\n                      <jats:sup>0<\/jats:sup>\n                      , HZ\n                      <jats:sup>1<\/jats:sup>\n                      , and HZ\n                      <jats:sup>\u22652<\/jats:sup>\n                      groups. Factors associated with HZ development were assessed using multivariable logistic regression. Patients were asked about willingness to receive RZV (\u201cyes\u201d, \u201cno\u201d, or \u201cnot sure\u201d) and reasons for the response.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 170 patients with SLE, 73 (43%) reported at least one HZ episode after SLE diagnosis, and 29 (40% of those with HZ) reported recurrent HZ. During 3138 person-years of follow-up, at least 102 HZ episodes were reported, yielding a minimum incidence of 32.5 per 1000 person-years. In multivariable analysis, ever use of azathioprine (OR 2.74, 95% CI 1.03\u20137.29) and renal dysfunction (OR 2.59, 95% CI 1.04\u20136.48) were associated with HZ development. Attitude data were available for 159 patients: 31 (20%) were willing to receive RZV, 47 (30%) were unwilling, and 81 (50%) were unsure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HZ was common and frequently recurrent in this Japanese SLE cohort. Ever use of azathioprine and renal dysfunction were associated with HZ development, while willingness to receive RZV was low. Risk-stratified clinician counselling and shared decision-making may improve acceptance of HZ prevention strategies in high-risk patients with SLE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09612033261493819","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:52:01Z","timestamp":1790599921000},"page":"1515-1525","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden of herpes zoster and recombinant zoster vaccine willingness in systemic lupus erythematosus: A single-center cohort study"],"prefix":"10.1177","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1718-0752","authenticated-orcid":false,"given":"Yuhei","family":"Fujisawa","sequence":"first","affiliation":[{"name":"Osaka Metropolitan University Graduate School of Medicine"},{"name":"Ohno Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuhei","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[{"name":"Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Katsushima","sequence":"additional","affiliation":[{"name":"Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Yamada","sequence":"additional","affiliation":[{"name":"Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomu","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Osaka Metropolitan University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa478"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/003591576505800106"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070739"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1544218"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-011-0162-0"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603800"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11369-5"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.9053"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab629"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25045"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215882"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"issue":"2","key":"e_1_3_7_18_2","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman DD","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29(2): 288\u2013291.","journal-title":"J Rheumatol"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400506"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00857-0"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0729"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.8.630"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-003-0403-3"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181d52ed7"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1807-59322011000700009"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312470186"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.39670"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320923739"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000574"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06450-2"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1293269"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2025-001718"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roaf061"},{"issue":"7","key":"e_1_3_7_37_2","first-page":"1254","article-title":"Herpes zoster in systemic lupus erythematosus","volume":"22","author":"Manzi S","year":"1995","unstructured":"Manzi S, Kuller LH, Kutzer J, et al. Herpes zoster in systemic lupus erythematosus. J Rheumatol 1995; 22(7): 1254\u20131258.","journal-title":"J Rheumatol"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.059"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9090963"},{"issue":"6","key":"e_1_3_7_40_2","first-page":"6222","article-title":"Herpes zoster in patients with systemic lupus erythematosus: clinical features, complications and risk factors","volume":"14","author":"Chen D","year":"2017","unstructured":"Chen D, Li H, Xie J, et al. Herpes zoster in patients with systemic lupus erythematosus: clinical features, complications and risk factors. Exp Ther Med 2017; 14(6): 6222\u20136228. https:\/\/doi.org\/10.3892\/etm.2017.5297","journal-title":"Exp Ther Med"},{"key":"e_1_3_7_41_2","first-page":"174891","article-title":"Herpes Zoster infections in SLE in a university Hospital in Saudi Arabia: risk factors and outcomes","volume":"2010","author":"Sayeeda A","year":"2010","unstructured":"Sayeeda A, Al Arfaj H, Khalil N, et al. Herpes Zoster infections in SLE in a university Hospital in Saudi Arabia: risk factors and outcomes. Autoimmune Dis. 2010; 2010: 174891. https:\/\/doi.org\/10.4061\/2010\/174891","journal-title":"Autoimmune Dis"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)90132-5"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033261493819","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09612033261493819","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033261493819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:23:18Z","timestamp":1794072198000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09612033261493819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":41,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10.1177\/09612033261493819"],"URL":"https:\/\/doi.org\/10.1177\/09612033261493819","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}